Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
What Torrent files
- Others113
- Investor Meet33
- Updates31
- Important30
- Dividend/Bonus14
- QIP/Rights/Pref.12
Torrent Pharma received an independent ESG Rating of 70 from NSE Sustainability Ratings & Analytics. This reflects its Environmental, Social, and Governance performance.
Torrent Pharma reports strong quarterly results: revenue surged 55% to ₹4,921 Cr, with Op. EBITDA up 61% to ₹1,664 Cr. Net Profit reached ₹566 Cr. The significant JB Pharma amalgamation is now complete, setting a new financial base for the company.
Torrent Pharma received final listing and trading approval for 4,19,22,416 new equity shares issued under the J.B. Chemicals amalgamation. These shares will now trade on NSE and BSE, increasing the company's free float and liquidity.
Torrent Pharma allotted 4.19 Cr new equity shares to former JB Chemicals shareholders, finalizing their amalgamation. This increased Torrent Pharma's paid-up equity capital from ₹169.22 Cr to ₹190.18 Cr, expanding its share base.
Torrent Pharma has dissolved its Philippines subsidiary, Curatio Inc. For FY26, the unit contributed nil turnover and had a net worth of only Rs 1.3 Cr (0.02%), indicating minimal financial impact from this operational change.